FDA Approved: RIDAURA — Supplemental Application (Sebela Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved a supplemental application for RIDAURA (auranofin) by Sebela Pharmaceuticals Inc., extending regulatory authorization for the existing drug.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• RIDAURA (auranofin)

Snippet

SUPPL AP for RIDAURA (AURANOFIN)